Transformational Frontiers Group scientists recognized by most selective NIH grants
October 6, 2017
The National Institutes of Health has announced their 2017 cohort of awardees in the High-Risk, High-Reward Research program, a national effort to recognize and support exceptionally creative ideas that offer unprecedented insights into biology. In the most competitive awards, the NIH Director’s Pioneer Awards and the NIH Director’s Transformative Research Awards, our Allen Distinguished Investigators and Allen Discovery Center leaders comprised an amazing 25% and 38% of the awards, respectively. In the broader category of NIH Early Independence Awards, an Allen Distinguished Investigator received one of 11 total national awards.
This notably extensive presence of Frontiers Group awardees among this groundbreaking national cohort demonstrates the successful curation of frontier talents among the researchers funded by The Paul G. Allen Frontiers Group. Private philanthropic funding is invaluable in uncovering this kind of pioneering talent and promoting the frontier thinking needed to create a healthy future.
The awardees are:
NIH Director’s Pioneer Award
- Feng Zhang, Ph.D., Allen Distinguished Investigator
- Jeffrey Macklis, M.D., D.HST., Allen Distinguished Investigator
- Alex Schier, Ph.D., team member of Allen Discovery Center at UW Medicine
NIH Director’s Transformative Research Award
- Ed Boyden, Ph.D., Allen Distinguished Investigator
- Long Cai, Ph.D., Allen Distinguished Investigator
- Michael Elowitz, Ph.D., Allen Distinguished Investigator
NIH Director’s Early Independence Award
- Fei Chen, Ph.D., Allen Distinguished Investigator
To learn more about all the awardees and the NIH High-Risk, High-Reward program, read their press release.